CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities
Net loss	$ (1,805,687)	$ (1,462,546)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	12,754	12,549
Amortization of debt discounts	196,797
Amortization of stock based prepaid consulting		42,500
Stock option employee compensation expense	665,410	412,724
Cost of repricing warrants to induce exercise	70,491
Changes in assets and liabilities:
Accounts receivable	24,537	(6,863)
Inventories	(16,744)	(186,402)
Prepaid expenses and other current assets	7,427	5,819
Accounts payable	(76,063)	66,133
Accrued expenses	(22,113)	(96,253)
Net cash used in operating activities	(943,191)	(1,212,339)
Cash flows from Investing Activities
Purchases of equipment	(2,185)	(26,922)
Net cash (used in) investing activities	(2,185)	(26,922)
Cash flows from Financing Activities
Proceeds from sale of stock through private placements	128,000
Proceeds from sale of stock to under stock purchase agreement	720,003
Proceeds from exercise of warrants	870,000
Proceeds from exercise of stock options		30,000
Payment on related party note	(33,339)
Proceeds from convertible notes with third parties	175,000
Payments on Insurance Finance Contract	(10,638)	(11,342)
Net cash provided by financing activities	1,849,026	18,658
Net increase (decrease) in cash and cash equivalents	903,650	(1,220,603)
Cash and cash equivalents - beginning	84,194	1,956,976
Cash and cash equivalents - ending	987,844	736,373
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	296	440
Cash paid for income taxes
Supplementary Disclosure of Non-cash Investing and Financing Activities:
Financing of prepaid insurance contracts	12,774	12,648
Beneficial conversion feature of convertible notes	166,709
Conversion of notes for common stock	$ 332,996